{"text": "value trap since 21 because of the gild terms"}
{"text": "6r day had a great live trade together session with we took a live trade on afrm to the longside which unfortuantely has failed we also created some plans to play later on the day one of which was gild reverse h amp s on the 60m chart"}
{"text": "a bit riskier perhaps but also started a position in gild today near support i like what it s cooking up in oncology and it remains the standard in hiv treatment the 4 dividend doesn t hurt either"}
{"text": "biocentury s latest round up of management moves roches perettie will head cell therapy at kite plus ochre appointsforster as chairperson and updates from verismo mig and women in bio gild"}
{"text": "truist initiated aclx buy 60 arcellx s platform partner favorably differentiate its lead asset while giving it the required edge needed to better its peers truist ests co reaches profit in 2027 there are multi oppys for clinical regulatory catalysts to add value kite gild"}
{"text": "gild jnj bmy arcellx a buy at truist on unique cancer cell therapies"}
